Galectin-3: A New Biomarker for Atherosclerosis Management

Abstract

Get full access to this article

View all access options for this article.

References

Oyenuga

Folsom

Fashanu

Aguilar

Ballantyne

. Plasma galectin-3 and sonographic measures of carotid atherosclerosis in the atherosclerosis risk in communities study. Angiology. 2019;70:47–55.

Ipek Gucuk

Suljevic

Kafes

, et al. Evaluation of galectin-3 levels in acute coronary syndrome. Ann Cardiol Angeiol (Paris). 2016;65:26–30.

Sharma

Mosleh

Chaudhari

, et al. Myocardial and serum galectin-3 expression dynamics marks post-myocardial infarction cardiac remodelling. Heart Lung Circ. 2017;26:736–45.

Yan

Lang

Vemuganti

Dempsey

. Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 2009;1288:116–24.

Christenson

Duh

, et al. Multi-center determination of galectin-3 assay performance characteristics: anatomy of a novel assay for use in heart failure. Clin Bio chem. 2010;43:683–90.

Meijers

van der Velde

de Boer

. The architect galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failure. Expert Rev Mol Diagn. 2014;14:257–66.